Arrowhead Pharmaceuticals, Inc. (ARWR)

Last Closing Price: 73.09 (2026-06-05)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Arrowhead Pharmaceuticals, Inc. (ARWR) had Net Income of $-132.73M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$73.74M
Net Income
$-132.73M
--
$73.74M
$215.00M
$-141.26M
$3.69M
$-137.56M
$-130.85M
$-137.57M
$-137.57M
$-137.57M
$-130.85M
$-141.26M
$-136.75M
142.42M
142.42M
$-0.93
$-0.93
Balance Sheet Financials
$1.84B
$374.82M
$428.51M
$2.27B
$295.22M
$841.58M
$1.37B
$1.67B
$598.92M
$592.90M
$598.92M
140.57M
Cash Flow Statement Financials
$97.92M
$-918.02M
$780.97M
$226.55M
$188.52M
$-38.03M
$36.04M
$-41.51M
--
Fundamental Metrics & Ratios
6.23
--
--
0.58
1.47
100.00%
-191.57%
-191.57%
--
-186.56%
-180.01%
$93.21M
--
--
--
0.03
--
4.70
19.14
-22.97%
-23.20%
-6.07%
-9.55%
$4.26
$0.65
$0.69